Albumin versus no albumin in decompensated cirrhosis with bacterial infection and systemic inflammatory response

Phase 3, randomised, open-label trial of human albumin in Cirrhosis and bacterial disease (2 arms), sponsored by CHU de Besançon. Primary endpoints: Primary endpoint definition for patients with normal renal function at baseline and Primary endpoint definition for patients with renal impairment at baseline. Started Jun 2008; status: active.